Avalon and GSK launch and fund three new life science companies
Avalon Ventures and GlaxoSmithKline has launched Adrenergics Inc, CadheRx Therapeutics Inc and Calporta Therapeutics Inc, three San Diego-based early-stage life science companies. Each will receive up to $10 million in Series A funding as well as R & D support from Avalon Ventures and GSK.
15 June 2015•4 mins read
